Article
High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
Antimicrobial agents and chemotherapy - 1 Feb 2017
Ponce Carolina A, Chabé Magali, George Claudio, Cárdenas Alejandra, Durán Luisa, Guerrero Julia, Bustamante Rebeca, Matos Olga, Huang Laurence, Miller Robert F, Vargas Sergio L
Abstract excerpt
Mutations in the dihydropteroate synthase (DHPS) gene of Pneumocystis jirovecii are associated with the failure of sulfa prophylaxis. They can develop by selection in patients receiving sulfa drugs or be acquired via person-to-person transmission. DHPS mutations raise concern about the decreasing efficacy of sulfa drugs, the main available therapeutic tool for Pneumocystis pneumonia (PCP). The prevalence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
